CDKN1A and glioblastoma: Consistent with observations in 3065-c475, BMP4 treatment resulted in significant growth inhibition, elevated SA-β-gal activity and p21 expression, and reduced lamin B1 expression, supporting senescence as a general response to BMP4 in therapy-resistant GBM cells (Supplementary Figure S4).